Iowa
Dr. Carter Friedt is a critical care pharmacist whose residency research focused on evaluating scheduled oral phosphorus supplementation in patients receiving continuous renal replacement therapy. His work contributes to optimizing electrolyte management and improving safety outcomes in critically ill populations. He currently practices at the University of Iowa Health Care, where he continues to advance evidence-based care in the intensive care unit.
Evaluation of Scheduled Oral Phosphorus in Patients on CRRT
Monday, March 23, 2026
9:00 AM - 10:00 AM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.